Aphakia Market Report 2026

The aphakia market size has grown rapidly in recent years. It will grow from $1.89 billion in 2025 to $2.12 billion in 2026 at a compound annual growth rate (CAGR) of 12.4%. The growth in the historic period can be attributed to rising cataract surgery volumes, improvements in ophthalmic surgical techniques, increased availability of corrective vision devices, expansion of ophthalmology clinics, growing awareness of visual impairment management.

The aphakia market size is expected to see rapid growth in the next few years. It will grow to $3.37 billion in 2030 at a compound annual growth rate (CAGR) of 12.2%. The growth in the forecast period can be attributed to increasing innovation in intraocular lens technologies, rising adoption of minimally invasive eye surgeries, expansion of personalized vision correction solutions, growing focus on pediatric ophthalmic care, increasing investments in advanced eye care infrastructure. Major trends in the forecast period include increasing adoption of intraocular lens implantation, rising demand for advanced refractive surgery options, growing use of customized contact lens solutions, expansion of pediatric aphakia management approaches, enhanced focus on post-surgical visual rehabilitation.

The increasing prevalence of cataracts is expected to drive the growth of the aphakia market in the coming years. Cataracts are a condition in which the eye's lens becomes cloudy, resulting in impaired vision. The number of cataract cases is rising due to aging populations, higher incidences of diabetes, prolonged exposure to sunlight, smoking, and poor nutrition. Cataracts lead to aphakia by requiring the removal of the eye's natural lens during surgery to treat the clouded lens, leaving the eye without its natural lens. For example, in May 2024, according to the Office for Health Improvement and Disparities, a UK-based government body, cataract surgery admissions in England among individuals aged 65 and over increased from 516,073 in the financial year ending 2023 to 581,369 in the financial year ending 2024, indicating a significant rise in demand for surgical treatment. Consequently, the growing prevalence of cataracts is fueling the aphakia market.

Major companies operating in the aphakia market are focusing on developing presbyopia-correcting intraocular lenses (IOLs) to improve visual outcomes and patient satisfaction. Presbyopia-correcting IOLs address aphakia by restoring vision and correcting presbyopia, enabling clear sight at multiple distances without the need for additional eyewear. For example, in November 2023, Alcon, a Switzerland-based surgical equipment company, introduced Clareon Vivity in Canada. This innovative nondiffractive extended depth of focus (EDOF) intraocular lens (IOL) provides high-quality vision with minimal visual disturbances. The Clareon Vivity IOL is designed to treat aphakia, a condition in which the eye's natural lens has been removed, usually during cataract surgery. By employing x-wave technology, it enhances focus without splitting the wavefront, reducing halos and delivering a more precise visual experience. This advancement represents a notable development in the aphakia market, offering cataract patients an improved option for presbyopia correction.

In July 2024, iCare Health Solutions, a US-based ocular care services company, acquired Beraja Medical Group for an undisclosed amount. Through this acquisition, iCare Health Solutions plans to expand its eyecare services and enhance patient outcomes. This initiative aims to increase access to high-quality care and incorporate established expertise into iCare’s network. It also ensures the continuation of local operations and retention of familiar staff for the community. Beraja Medical Group is a US-based company focused on comprehensive ophthalmology, with expertise in advanced eye care and aesthetic services, including aphakia.

Major companies operating in the aphakia market are Johnson & Johnson Services Inc., Alcon Laboratories Inc., Hoya Corporation, CooperVision Inc., Carl Zeiss AG, Santen Pharmaceutical Co. Ltd., Appasamy Associates, Aurolab, Rayner Intraocular Lenses Limited, Ophtec BV, SIFI SpA, Aaren Scientific Inc., Mediphacos, Hanita Lenses Ltd., Menicon Co. Ltd., Lenstec Inc., Morcher GmbH, Bausch & Lomb Incorporated, Nidek Co. Ltd., Swiss Advanced Vision AG, UltraVision CLPL, Medennium Inc.

North America was the largest region in the aphakia market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the aphakia market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the aphakia market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the aphakia market by increasing costs of imported intraocular lenses, ophthalmic surgical instruments, optical materials, and precision manufacturing equipment. Eye care hospitals and ophthalmic clinics in North America and Europe are most affected due to reliance on imported lenses and devices, while Asia-Pacific faces cost pressure in lens manufacturing and exports. These tariffs are contributing to higher procedure and device costs. However, they are also encouraging local production of intraocular lenses, regional supply chain development, and investment in domestic ophthalmic device manufacturing capabilities.

The aphakia market research report is one of a series of new reports that provides aphakia market statistics, including aphakia industry global market size, regional shares, competitors with a aphakia market share, detailed aphakia market segments, market trends and opportunities, and any further data you may need to thrive in the aphakia industry. This aphakia market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Aphakia is the absence of the crystalline lens in the eye, which can lead to significant visual impairment because the lens is crucial for focusing light onto the retina. This can occur due to surgical removal of the lens (cataract surgery), trauma, or other conditions that lead to the loss of the natural lens.

The main types in the aphakia market are congenital aphakia, surgical aphakia, and acquired aphakia. Congenital aphakia refers to a condition present at birth where an individual is born without a natural lens in one or both eyes. The various treatments include spectacles, contact lenses, intraocular lens implantation, and refractive surgery, and end user involve are hospitals, ophthalmic clinics, and others.

The aphakia market consists of revenues earned by entities by providing services such as diagnosis, surgical implantation of intraocular lenses (IOLs), postoperative care, and rehabilitation. The market value includes the value of related goods sold by the service provider or included within the service offering. The aphakia market also includes sales of intraocular lenses (IOLs), contact lenses, spectacles, and ocular implants. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.